Investor Centre

Investor Fact Sheet

Name: Cann Group Limited
Business Description:

Cann is the first Australian company to secure the necessary licences to undertake research and to cultivate cannabis for human medicinal and research purposes under the Australian Government’s new medicinal cannabis regulatory system. Cann is building an Australian based business intended to take advantage of opportunities relating to the emerging medicinal cannabis industry.

Cann has established facilities and systems which can cultivate medicinal cannabis in accordance with the requirements under the Narcotic Drugs Act 1967 (ND Act). In due course, Cann intends to extend its operational activities to the manufacturing of medicinal cannabis products.

Cann’s vision is to be a leading developer and supplier of cannabis, cannabis resin and medicinal cannabis products into the Australian market, and to supply overseas markets as those opportunities become available.

Business Established: 30 January 2015
Board of Directors:

Allan McCallum
Philip Jacobsen
Doug Rathbone
Geoff Pearce

CEO:

Peter Crock

Company Secretary:

Richard Baker

Office:

Level 2,
409 St Kilda Road
Melbourne, Victoria, 3004

Share Registry:

Link Market Services Limited
Tower 4,
727 Collins Street
Melbourne, Victoria, 3008
Ph: 1300 554 474

Auditors:

William Buck Audit (VIC) Pty Ltd
Level 20,
181 William Street
Melbourne, Victoria, 3000
Ph: 03 9824 8555